New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol

Journal of the American Pharmacists Association

Volumn 50, Issue 5, 2010, Pages 658-660

  Hussar, Daniel A ^a   Stevenson, Takyiah ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b Walgreens   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DENOSUMAB; DIENOGEST; DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL VALERATE; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; NANDROLONE; OSTEOCLAST DIFFERENTIATION FACTOR; POLIDOCANOL; SCLEROSING AGENT; TNFSF11 PROTEIN, HUMAN;

ARTICLE; DRUG POTENTIATION; FEMALE; HUMAN; MALE; POSTMENOPAUSE OSTEOPOROSIS;

ANTIBODIES, MONOCLONAL; CONTRACEPTIVE AGENTS; ESTRADIOL; FEMALE; HUMANS; MALE; NANDROLONE; OSTEOPOROSIS, POSTMENOPAUSAL; POLYETHYLENE GLYCOLS; RANK LIGAND; SCLEROSING SOLUTIONS;

EID: 79952782200     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.10536     Document Type: Article

References (0)